JP2006521334A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521334A5
JP2006521334A5 JP2006505750A JP2006505750A JP2006521334A5 JP 2006521334 A5 JP2006521334 A5 JP 2006521334A5 JP 2006505750 A JP2006505750 A JP 2006505750A JP 2006505750 A JP2006505750 A JP 2006505750A JP 2006521334 A5 JP2006521334 A5 JP 2006521334A5
Authority
JP
Japan
Prior art keywords
wax
lipid
solid particles
solid
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006505750A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006521334A (ja
JP5072355B2 (ja
Filing date
Publication date
Priority claimed from FR0303568A external-priority patent/FR2852843B1/fr
Application filed filed Critical
Publication of JP2006521334A publication Critical patent/JP2006521334A/ja
Publication of JP2006521334A5 publication Critical patent/JP2006521334A5/ja
Application granted granted Critical
Publication of JP5072355B2 publication Critical patent/JP5072355B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006505750A 2003-03-24 2004-03-24 有効成分輸送のための新規なガレヌス製剤系、調製方法及び使用 Expired - Fee Related JP5072355B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0303568A FR2852843B1 (fr) 2003-03-24 2003-03-24 Systeme galenique permettant le masquage du gout
FR03/03568 2003-03-24
PCT/FR2004/000729 WO2004084856A2 (fr) 2003-03-24 2004-03-24 Nouveau systeme galenique pour le transport d’actif, procede de preparation et utilisation

Publications (3)

Publication Number Publication Date
JP2006521334A JP2006521334A (ja) 2006-09-21
JP2006521334A5 true JP2006521334A5 (https=) 2011-03-31
JP5072355B2 JP5072355B2 (ja) 2012-11-14

Family

ID=32947122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505750A Expired - Fee Related JP5072355B2 (ja) 2003-03-24 2004-03-24 有効成分輸送のための新規なガレヌス製剤系、調製方法及び使用

Country Status (10)

Country Link
US (3) US20070116728A1 (https=)
EP (1) EP1605918B1 (https=)
JP (1) JP5072355B2 (https=)
KR (1) KR20060012576A (https=)
AU (1) AU2004224601A1 (https=)
CA (1) CA2519962C (https=)
FR (1) FR2852843B1 (https=)
MX (1) MXPA05010217A (https=)
NZ (1) NZ542590A (https=)
WO (1) WO2004084856A2 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
FR2879930B1 (fr) * 2004-12-23 2007-08-31 Oralance Pharma Sa Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
US8613956B2 (en) * 2008-06-23 2013-12-24 International Flora Technologies, Ltd. Cosmetic particles that transform from hard to soft particles comprising hydrogenated long-chain triglyceride oils
FR2935270A1 (fr) * 2008-08-28 2010-03-05 Oralance Pharma Composition pharmaceutique de temozolomide pour usage pediatrique
EP2908930A1 (en) * 2012-10-18 2015-08-26 DSM IP Assets B.V. Beadlets comprising carotenoids
EP2964243B1 (en) * 2013-03-06 2022-11-23 Capsugel Belgium NV Curcumin solid lipid particles and methods for their preparation and use
EP3766480A1 (en) 2014-06-10 2021-01-20 Capsugel Belgium NV Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
US11324699B2 (en) 2014-12-04 2022-05-10 Capsugel Belgium Nv Lipid multiparticulate formulations
EP3236993B1 (en) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
PL3551164T3 (pl) * 2016-12-08 2021-09-27 Salsarulo Pharma Lek doustny zawierający osmotyczny środek przeczyszczający wprowadzony do w matrycy na bazie tłuszczów roślinnych
US10639607B2 (en) 2017-06-16 2020-05-05 Matralix Pte Ltd Systems and methods for preparing wax and lipid particles
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
CA3087569A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
BR112020017090A8 (pt) 2018-02-23 2022-07-05 Crestovo Holdings Llc Imunoterapias relacionadas com microbioma
FR3078630B1 (fr) * 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe
WO2019183208A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
EP4275761A3 (en) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
FR3079146B1 (fr) * 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.
CA3146738A1 (en) 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
US12290538B2 (en) 2019-07-19 2025-05-06 Finch Therapeutics Holdings Llc Methods and products for treatment of gastrointestinal disorders
CN114650833A (zh) 2019-09-13 2022-06-21 芬奇治疗控股有限责任公司 用于治疗孤独症谱群障碍的组合物和方法
AU2020366529A1 (en) 2019-10-18 2022-05-19 Finch Therapeutics Holdings Llc Compositions and methods for delivering a bacterial metabolite to a subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療b型肝炎(hbv)及d型肝炎(hdv)之組合物及方法
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
CN113308045B (zh) * 2021-05-28 2022-03-22 宁波市鑫晟工贸实业有限公司 一种抗老化的塑料盒及其制备方法
IT202100014330A1 (it) * 2021-06-01 2022-12-01 The Ubeauty Com Llc Prodotto per la cura della pelle e procedimento per la sua realizzazione.
JP2025506168A (ja) * 2022-02-11 2025-03-07 インシツ バイオロジクス、インク. 持続放出癌治療用製剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
GB1323161A (en) * 1970-02-16 1973-07-11 Wyeth John & Brother Ltd Penicillin composition
US4132375A (en) * 1976-01-21 1979-01-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Vortex-lift roll-control device
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
JPS63301815A (ja) * 1987-01-29 1988-12-08 Taisho Pharmaceut Co Ltd 経口製剤の製造方法
JP2700662B2 (ja) * 1988-06-22 1998-01-21 大正製薬株式会社 被覆製剤
JPH02200639A (ja) * 1989-01-31 1990-08-08 Shinfusou Seiyaku Kk 脂質被覆細菌製剤
IT1229856B (it) 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
US5213810A (en) 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
ES2086022T3 (es) 1991-07-23 1996-06-16 American Cyanamid Co Composiciones estables para administracion parenteral y su uso.
DE4131562A1 (de) 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
ES2194863T3 (es) * 1992-11-30 2003-12-01 Kv Pharm Co Materiales farmaceuticos con enmascarado de sabor.
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4308282C2 (de) 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
KR20010012402A (ko) 1997-05-09 2001-02-15 세이지 파마슈티칼스, 인크. 안정한 약제학적 경구 투여형
WO1999013864A2 (en) * 1997-09-19 1999-03-25 Shire Laboratories, Inc. Solid solution beadlet
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
FR2779962B1 (fr) * 1998-06-17 2002-12-06 Karim Ioualalen Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation
MXPA01011343A (es) 1999-05-07 2002-06-04 Pharmasol Gmbh Particulas de lipidos a base de mezclas de lipidos liquidos y solidos asi como procedimiento para su produccion.
EP1183014B1 (en) 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
EP1197207B1 (en) * 2000-10-10 2008-04-23 Wyeth Holdings Corporation Stable compositions for parenteral administration
JP3597823B2 (ja) 2002-02-07 2004-12-08 沢井製薬株式会社 固形製剤
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout

Similar Documents

Publication Publication Date Title
JP2006521334A5 (https=)
US5385737A (en) Surfactant-containing seamless capsules
AU650683B2 (en) Melt granulating method for drug formulation
ES2598482T3 (es) Formulaciones de enzimas mejoradas para pienso
JP4256787B2 (ja) 有益物質粒子を含む秩序液晶性洗浄組成物
TW202034896A (zh) 含乙酸纖維素之粒子、化妝品組成物及含乙酸纖維素之粒子之製造方法
JPH0475054B2 (https=)
PL191147B1 (pl) Sposób wytwarzania koncentratu środka zapachowego i wyrobu zawierającego ten koncentrat oraz wyrób zawierający koncentrat środka zapachowego, a zwłaszcza świeca z udziałem parafiny
JPS60116627A (ja) 脈管内輸送用微小球の製法
JP6681918B2 (ja) カプセルの製造方法
CA1187795A (en) Method for preparing galenic formulations particularly for pharmaceutical, dietetical, cosmetic and diagnostic uses
JPH0348604A (ja) 非親水性、リポイド状物質のスフィロイドを懸濁状で含む水性ゲル化粧用組成物
HUE032736T2 (en) Feed additive preparation containing an acidic or neutral amino acid for ruminant animals, and a method for producing it
JP2020514044A (ja) 少なくとも1種の揮発性化合物を含むカプセルを製造する方法およびその方法から得られるカプセル
JP2002504425A (ja) ミクロ粒子又はナノ粒子製造用マトリックス、前記粒子の製造方法及び得られる粒子
KR101681073B1 (ko) 리피드 캡슐 함유 화장료 조성물 및 이의 제조방법
JP4823675B2 (ja) ハイドロゲル粒子の製造方法、並びに、それによって製造されるハイドロゲル粒子及びそれを用いた分散体
JP2003055219A (ja) マイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
JP7510250B2 (ja) 細塵除去用多孔性複合粉体及びその製造方法
JPH0279935A (ja) バター様スプレッド
JP2019523317A (ja) 固形石鹸組成物
JP2002104958A (ja) 親油性ビタミン製剤
JPH0657290A (ja) チキソトロピーを有するゲル状組成物
JP2000086502A (ja) 徐放性マイクロスフエアの製造法
HRP20220965T1 (hr) Formulacija probavnog enzima za oslobađanje u crijevima, postupak proizvodnje i galenski pripravak